Login to Your Account



Baby steps: Discovery plans phase IIb to test Aerosurf again in RDS

By Randy Osborne
Staff Writer

Thursday, November 12, 2015

With a "groundwork of foundational support" for Aerosurf from top-line phase IIa data plus previous work, Discovery Laboratories Inc. is going into phase IIb development of the aerosolized KL4 surfactant for preventing RDS in premature infants, CEO John Cooper said.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription